Trial | NCT04256824  Report issue

Title

Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds
Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds; Multi-center, Double Blind, Randomized Study

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Recruiting

  • Study Participants

    430
Comparing the incidence of SSI in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery
Comparing the incidence of surgical site infection (SSI) in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery. Also, comparing the post hospital stay.
Study Started
Feb 05
2020
Primary Completion
Oct 10
2023
Anticipated
Study Completion
Jan 30
2024
Anticipated
Last Update
Sep 06
2023

Drug coated vicryl plus [triclosan, polyglactin 910]

Coated Polyglactin 910 with Triclosan (coated vicryl plus)

  • Other names: Coated Polyglactin 910 with Triclosan

Drug Vicryl [triclosan, polyglactin 910]

Coated Polyglactin 910 without Triclosan (vicryl)

  • Other names: Coated Polyglactin 910 without Triclosan

Coated Polyglactin 910 with Triclosan Experimental

Coated vicryl plus

Coated Polyglactin 910 without Triclosan Active Comparator

Coated vicryl

Criteria 

Inclusion Criteria:

age: 18-75
clean-contaminated wound surgery

Exclusion Criteria:

Patient has immunodeficiency disorder.
Patient receiving anti-cancer / immunosuppressive therapy.
Patients with established pre-operative infection whether community acquired or hospital acquired either at / remote from the operative site.
No Results Posted